Blake M. Warner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Blake M. Warner has a total of 674 co-authors. Here are the top co-authors by number of shared publications:
Paola Perez
Salivary Disorders Unit, NIDCR, NIH, Bethesda, MD, USA
13 shared publicationsEileen Pelayo
National Institute of Dental and Craniofacial Research, National Institutes of Health Bethesda Maryland USA
11 shared publicationsJohn A. Chiorini
Adeno-Associated Virus Biology Section, NIDCR, NIH, Bethesda, MD, USA
11 shared publicationsDaniel Martin
NIDCD, NIH, Bethesda, MD, USA
9 shared publicationsDavid E. Kleiner
Sjögren’s Disease Clinic, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
9 shared publicationsZohreh Khavandgar
National Institute of Dental and Craniofacial Research, National Institutes of Health Bethesda Maryland USA
8 shared publications
Latest Publications
- Open Access
ZBTB7B is a Master Regulator of Salivary Acinar Cell Function
Salivary glands exhibit transcriptional programs that distinguish them from other tissues, yet the upstream regulatory logic underlying these programs is not well defined. To identify transcription factors (TFs) that structure salivary identity, we generated RNA-seq and ATAC-seq from human major and minor salivary glands and inferred TF→TF regulatory edges from high-confidence chromatin footprints. ZBTB7B emerged as the most connected regulator across salivary samples. To locate regulatory regions associated with salivary-specific transcription, we trained hidden Markov models (HMMs) on chromatin accessibility across 4 Mbp windows surrounding salivary-specific and non-salivary-specific transcription start sites. The resulting chromatin states distinguished promoter-proximal openness from distal enhancer activity and identified salivary-specific enhancers enriched for ZBTB7B motifs. These enhancer states correlated strongly with expression of salivary genes, including AQP5, indicating that distal regulation contributes substantially to salivary transcriptional specificity. To assess the consequences of losing Zbtb7b, we performed single-cell RNA-seq and spatial transcriptomics on submandibular and parotid glands from Zbtb7b knockout mice. Knockout mice exhibited reduced salivary flow, shifts in acinar cell proportions, and the emergence of a neonate-like acinar population characterized by loss of canonical secreted proteins and increased expression of MHC class I genes. These transcriptional and cellular changes occurred despite preserved gland architecture, suggesting that Zbtb7b stabilizes adult acinar identity rather than supporting structural maintenance. Together, these data identify ZBTB7B as a master regulator of salivary transcriptional networks, acting through both promoter-proximal and enhancer-level mechanisms, and demonstrate that loss of Zbtb7b disrupts acinar identity and impairs salivary function.
Open AccessZBTB7B is a Master Regulator of Salivary Acinar Cell Function
Salivary glands exhibit transcriptional programs that distinguish them from other tissues, yet the upstream regulatory logic underlying these programs is not well defined. To identify transcription factors (TFs) that structure salivary identity, we generated RNA-seq and ATAC-seq from human major and minor salivary glands and inferred TF→TF regulatory edges from high-confidence chromatin footprints. ZBTB7B emerged as the most connected regulator across salivary samples. To locate regulatory regions associated with salivary-specific transcription, we trained hidden Markov models (HMMs) on chromatin accessibility across 4 Mbp windows surrounding salivary-specific and non-salivary-specific transcription start sites. The resulting chromatin states distinguished promoter-proximal openness from distal enhancer activity and identified salivary-specific enhancers enriched for ZBTB7B motifs. These enhancer states correlated strongly with expression of salivary genes, including AQP5, indicating that distal regulation contributes substantially to salivary transcriptional specificity. To assess the consequences of losing Zbtb7b, we performed single-cell RNA-seq and spatial transcriptomics on submandibular and parotid glands from Zbtb7b knockout mice. Knockout mice exhibited reduced salivary flow, shifts in acinar cell proportions, and the emergence of a neonate-like acinar population characterized by loss of canonical secreted proteins and increased expression of MHC class I genes. These transcriptional and cellular changes occurred despite preserved gland architecture, suggesting that Zbtb7b stabilizes adult acinar identity rather than supporting structural maintenance. Together, these data identify ZBTB7B as a master regulator of salivary transcriptional networks, acting through both promoter-proximal and enhancer-level mechanisms, and demonstrate that loss of Zbtb7b disrupts acinar identity and impairs salivary function.
- Open Access
- 30 August 2026
- Published by Wiley in Oral Diseases
AQP1 Corrects Acinar Cells’ Secretion Deficits in Sjögren's Disease
Introduction: Sjögren's disease (SjD) is a systemic autoimmune disease characterized by dry mouth, dry eyes, and profound fatigue. Preclinical studies suggest that AQP1 gene expression in salivary glands corrects salivary hypofunction in preclinical and clinical studies of radiation‐induced xerostomia and improves salivary and lacrimal function in SjD mouse models. Subjects and Methods: To evaluate its therapeutic potential, we tested AQP1 gene therapy using labial salivary gland (LSG) biopsies from patients with SjD, non‐SjD, and healthy volunteer glands (HV). Results: Ex vivo cultures of LSG lobules were viable, responsive to stimulation, and transducible with an AAV2 vector encoding AQP1. AQP1 expression increased fluid secretion in most samples, with recovery reaching up to 80% of healthy volunteer levels. Baseline transcriptomic analysis identifies 94 genes that correlated with treatment response, with inflammatory and epithelial signature correlating with success and fibrotic signatures with non‐response. Histological evaluation confirmed greater fibrosis in non‐responding samples. Thus, treatment effects were functionally significant but transcriptionally minimal indicating targeted therapeutic action without altering homeostatic transcription. Conclusion: These findings demonstrate that AAV2‐AQP1 expression enhances fluid secretion in human LSGs and highlight fibrosis‐associated loss of glandular parenchyma as a major barrier to therapeutic efficacy.
- 30 August 2026
- Published by Wiley in Oral Diseases
Open AccessAQP1 Corrects Acinar Cells’ Secretion Deficits in Sjögren's Disease
Introduction: Sjögren's disease (SjD) is a systemic autoimmune disease characterized by dry mouth, dry eyes, and profound fatigue. Preclinical studies suggest that AQP1 gene expression in salivary glands corrects salivary hypofunction in preclinical and clinical studies of radiation‐induced xerostomia and improves salivary and lacrimal function in SjD mouse models. Subjects and Methods: To evaluate its therapeutic potential, we tested AQP1 gene therapy using labial salivary gland (LSG) biopsies from patients with SjD, non‐SjD, and healthy volunteer glands (HV). Results: Ex vivo cultures of LSG lobules were viable, responsive to stimulation, and transducible with an AAV2 vector encoding AQP1. AQP1 expression increased fluid secretion in most samples, with recovery reaching up to 80% of healthy volunteer levels. Baseline transcriptomic analysis identifies 94 genes that correlated with treatment response, with inflammatory and epithelial signature correlating with success and fibrotic signatures with non‐response. Histological evaluation confirmed greater fibrosis in non‐responding samples. Thus, treatment effects were functionally significant but transcriptionally minimal indicating targeted therapeutic action without altering homeostatic transcription. Conclusion: These findings demonstrate that AAV2‐AQP1 expression enhances fluid secretion in human LSGs and highlight fibrosis‐associated loss of glandular parenchyma as a major barrier to therapeutic efficacy.
- 3 July 2026
- Published by Elsevier in Oral Oncology
- Vol. 180, 108071
Aquaporin-1 gene therapy as a novel method to treat radiation-induced salivary gland damage: The case for adeno-associated virus vectors
- 3 July 2026
- Published by Elsevier in Oral Oncology
- Vol. 180, 108071
Aquaporin-1 gene therapy as a novel method to treat radiation-induced salivary gland damage: The case for adeno-associated virus vectors
- Open Access
ICI-induced Granulomatous Sialadenitis is Responsive to Prednisone
Immune checkpoint inhibitors (ICIs) have transformed cancer treatment but commonly cause immune-related adverse events (irAEs), whether administered as monotherapy or in combination with other oncological agents. We present the first reported case of ICI-induced granulomatous sialadenitis in a male patient in his mid-fifties with BRAF-V600E-mutated papillary thyroid carcinoma who received sequential treatment with BRAF/MEK inhibitors followed by pembrolizumab. The patient experienced acute-onset severe xerostomia and salivary hypofunction, prompting ICI cessation and salivary gland biopsy. Integrative analysis using histology, single-cell RNA sequencing, and spatial transcriptomics revealed macrophage- and T-cell-mediated epithelial damage driven by epithelial senescence and Th1-polarized inflammation. Corticosteroid therapy reduced granuloma burden and improved salivary flow rates and tissue architecture; however, extensive fibrosis persisted despite treatment. These findings underscore the critical importance of early irAE recognition and intervention to preserve glandular function and enable continuation of cancer therapy.
Open AccessICI-induced Granulomatous Sialadenitis is Responsive to Prednisone
Immune checkpoint inhibitors (ICIs) have transformed cancer treatment but commonly cause immune-related adverse events (irAEs), whether administered as monotherapy or in combination with other oncological agents. We present the first reported case of ICI-induced granulomatous sialadenitis in a male patient in his mid-fifties with BRAF-V600E-mutated papillary thyroid carcinoma who received sequential treatment with BRAF/MEK inhibitors followed by pembrolizumab. The patient experienced acute-onset severe xerostomia and salivary hypofunction, prompting ICI cessation and salivary gland biopsy. Integrative analysis using histology, single-cell RNA sequencing, and spatial transcriptomics revealed macrophage- and T-cell-mediated epithelial damage driven by epithelial senescence and Th1-polarized inflammation. Corticosteroid therapy reduced granuloma burden and improved salivary flow rates and tissue architecture; however, extensive fibrosis persisted despite treatment. These findings underscore the critical importance of early irAE recognition and intervention to preserve glandular function and enable continuation of cancer therapy.
- 30 November 2025
- Published by Wiley in Arthritis & Rheumatology
- Vol. 78 (4) , 791-800
Investigation of Lysosome‐Associated Membrane Protein 3 Highlighting the Role of Lysosome in Pathophysiology and Treatment of Sjögren Disease
Lysosome‐associated membrane protein 3 (LAMP3) is a unique lysosomal membrane protein specifically expressed in mature dendritic cells and type II pneumocytes. Its ectopic expression in salivary gland epithelial cells (SGECs) is induced by type I interferon (IFN) signaling and is further amplified through Toll‐like receptor 7 (TLR7) activation, which is implicated in the pathogenesis of Sjögren disease (SjD). This aberrant up‐regulation disrupts glandular function by promoting endolysosomal degradation of aquaporin 5 (AQP5) and sodium–potassium–chloride cotransporter 1, leading to impaired fluid secretion and associated clinical sequelae (eg, dry mouth). Additionally, LAMP3‐mediated lysosomal exocytosis of DAMPs enhances monocytic bone morphogenetic protein 6 (BMP6) production, which in turn suppresses AQP5 transcription. Moreover, LAMP3 drives the extracellular vesicle–mediated release of autoantigens, which further amplifies autoimmunity, and lysosome‐dependent cell death in SGECs contributes to tissue damage. These findings establish LAMP3 as a pivotal regulatory hinge in SjD pathogenesis, linking IFN/TLR7 signaling, lysosomal dysfunction, and glandular hypofunction. Its central role makes it a compelling therapeutic target, with strategies including IFN and TLR7 pathway inhibitors to limit its induction, restoration of lysosomal function, BMP6 inhibition to preserve AQP5 expression, and AQP gene therapy to improve fluid secretion.
- 30 November 2025
- Published by Wiley in Arthritis & Rheumatology
- Vol. 78 (4) , 791-800
Investigation of Lysosome‐Associated Membrane Protein 3 Highlighting the Role of Lysosome in Pathophysiology and Treatment of Sjögren Disease
Lysosome‐associated membrane protein 3 (LAMP3) is a unique lysosomal membrane protein specifically expressed in mature dendritic cells and type II pneumocytes. Its ectopic expression in salivary gland epithelial cells (SGECs) is induced by type I interferon (IFN) signaling and is further amplified through Toll‐like receptor 7 (TLR7) activation, which is implicated in the pathogenesis of Sjögren disease (SjD). This aberrant up‐regulation disrupts glandular function by promoting endolysosomal degradation of aquaporin 5 (AQP5) and sodium–potassium–chloride cotransporter 1, leading to impaired fluid secretion and associated clinical sequelae (eg, dry mouth). Additionally, LAMP3‐mediated lysosomal exocytosis of DAMPs enhances monocytic bone morphogenetic protein 6 (BMP6) production, which in turn suppresses AQP5 transcription. Moreover, LAMP3 drives the extracellular vesicle–mediated release of autoantigens, which further amplifies autoimmunity, and lysosome‐dependent cell death in SGECs contributes to tissue damage. These findings establish LAMP3 as a pivotal regulatory hinge in SjD pathogenesis, linking IFN/TLR7 signaling, lysosomal dysfunction, and glandular hypofunction. Its central role makes it a compelling therapeutic target, with strategies including IFN and TLR7 pathway inhibitors to limit its induction, restoration of lysosomal function, BMP6 inhibition to preserve AQP5 expression, and AQP gene therapy to improve fluid secretion.
- Open Access
- 28 October 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 85 (5) , 880-898
GZMK+CD8+ T cells target a specific acinar cell type in Sjögren's disease
- 28 October 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 85 (5) , 880-898
Open AccessGZMK+CD8+ T cells target a specific acinar cell type in Sjögren's disease
- 15 September 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 85 (2) , 351-359
Myositis-specific autoantibodies recognising Mi2 also target the AIRE protein at a shared PHD zinc finger
- 15 September 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 85 (2) , 351-359
Myositis-specific autoantibodies recognising Mi2 also target the AIRE protein at a shared PHD zinc finger
- Open Access
- 12 June 2025
- Published by Frontiers Media SA in Frontiers in Dental Medicine
- Vol. 6, 1590516
Multiparameter flow cytometry enables immune profiling and IFN pathway analysis in human minor salivary glands
Aim/Introduction: We aimed to achieve direct quantitative measurement of activated and therapeutically actionable pathways (e.g., Type-I interferon) in target organs of autoimmune disease using flow cytometry of human salivary glands. Sjögren's Disease (SjD) is a systemic autoimmune disorder characterized by lymphocytic inflammation and dysfunction of the lacrimal and salivary glands. Minor salivary glands are routinely biopsied and are used for the histopathological diagnosis of SjD. In this study, we optimized the dissociation, permeabilization, antibody panel, and analytical parameters to characterize both the immune and epithelial cells in the glands, and the activation status of a specified pathway by measuring intracellular phosphorylated proteins.Methods: Fresh human MSG biopsies were dissociated into single-cell suspensions and permeabilized under optimized conditions. MSG suspensions were stained for cell surface and intracellular markers then analyzed using nine-color conventional flow cytometry, including two intracellular markers.Results: Our optimized dissociation and permeabilization protocols for human MSG preserved key cell surface markers. Our flow cytometry panel identified major immune cell populations and distinguished epithelial cells via cytokeratin-18. We demonstrate the protocol's utility showing differential interferon pathway activity in SjD vs. healthy MSG leukocytes and epithelial cells. We provide guidance on panel selection, analytical capabilities, and the impact of cell yield on resolution using conventional flow cytometry.Conclusion: Our optimized protocol enables high-resolution characterization of immune and epithelial cell populations in human MSG, preserving key markers and capturing interferon pathway activity. Our protocol provides a robust framework for the direct study of immune heterogeneity and signaling dynamics in SjD at single cell resolution.
- 12 June 2025
- Published by Frontiers Media SA in Frontiers in Dental Medicine
- Vol. 6, 1590516
Open AccessMultiparameter flow cytometry enables immune profiling and IFN pathway analysis in human minor salivary glands
Aim/Introduction: We aimed to achieve direct quantitative measurement of activated and therapeutically actionable pathways (e.g., Type-I interferon) in target organs of autoimmune disease using flow cytometry of human salivary glands. Sjögren's Disease (SjD) is a systemic autoimmune disorder characterized by lymphocytic inflammation and dysfunction of the lacrimal and salivary glands. Minor salivary glands are routinely biopsied and are used for the histopathological diagnosis of SjD. In this study, we optimized the dissociation, permeabilization, antibody panel, and analytical parameters to characterize both the immune and epithelial cells in the glands, and the activation status of a specified pathway by measuring intracellular phosphorylated proteins.Methods: Fresh human MSG biopsies were dissociated into single-cell suspensions and permeabilized under optimized conditions. MSG suspensions were stained for cell surface and intracellular markers then analyzed using nine-color conventional flow cytometry, including two intracellular markers.Results: Our optimized dissociation and permeabilization protocols for human MSG preserved key cell surface markers. Our flow cytometry panel identified major immune cell populations and distinguished epithelial cells via cytokeratin-18. We demonstrate the protocol's utility showing differential interferon pathway activity in SjD vs. healthy MSG leukocytes and epithelial cells. We provide guidance on panel selection, analytical capabilities, and the impact of cell yield on resolution using conventional flow cytometry.Conclusion: Our optimized protocol enables high-resolution characterization of immune and epithelial cell populations in human MSG, preserving key markers and capturing interferon pathway activity. Our protocol provides a robust framework for the direct study of immune heterogeneity and signaling dynamics in SjD at single cell resolution.
- Open Access
- 21 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Deconvolution of cell types and states in spatial multiomics utilizing TACIT
Identifying cell types and states remains a time-consuming, error-prone challenge for spatial biology. While deep learning increasingly plays a role, it is difficult to generalize due to variability at the level of cells, neighborhoods, and niches in health and disease. To address this, we develop TACIT, an unsupervised algorithm for cell annotation using predefined signatures that operates without training data. TACIT uses unbiased thresholding to distinguish positive cells from background, focusing on relevant markers to identify ambiguous cells in multiomic assays. Using five datasets (5,000,000 cells; 51 cell types) from three niches (brain, intestine, gland), TACIT outperforms existing unsupervised methods in accuracy and scalability. Integrating TACIT-identified cell types reveals new phenotypes in two inflammatory gland diseases. Finally, using combined spatial transcriptomics and proteomics, we discover under- and overrepresented immune cell types and states in regions of interest, suggesting multimodality is essential for translating spatial biology to clinical applications.
- 21 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Open AccessDeconvolution of cell types and states in spatial multiomics utilizing TACIT
Identifying cell types and states remains a time-consuming, error-prone challenge for spatial biology. While deep learning increasingly plays a role, it is difficult to generalize due to variability at the level of cells, neighborhoods, and niches in health and disease. To address this, we develop TACIT, an unsupervised algorithm for cell annotation using predefined signatures that operates without training data. TACIT uses unbiased thresholding to distinguish positive cells from background, focusing on relevant markers to identify ambiguous cells in multiomic assays. Using five datasets (5,000,000 cells; 51 cell types) from three niches (brain, intestine, gland), TACIT outperforms existing unsupervised methods in accuracy and scalability. Integrating TACIT-identified cell types reveals new phenotypes in two inflammatory gland diseases. Finally, using combined spatial transcriptomics and proteomics, we discover under- and overrepresented immune cell types and states in regions of interest, suggesting multimodality is essential for translating spatial biology to clinical applications.
- Open Access
- 12 December 2024
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 20 (12) , e1012375
SARS-CoV-2 infection of salivary glands compromises the production of a secreted antifungal peptide with potential implications for development of oral candidiasis
Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen Candida albicans. Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and Candida colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin and amylase genes. In situ hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral Candida burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of C. albicans. Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of C. albicans in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study potentially implicate SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis.
- 12 December 2024
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 20 (12) , e1012375
Open AccessSARS-CoV-2 infection of salivary glands compromises the production of a secreted antifungal peptide with potential implications for development of oral candidiasis
Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen Candida albicans. Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and Candida colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin and amylase genes. In situ hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral Candida burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of C. albicans. Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of C. albicans in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study potentially implicate SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis.